Instituto de Salud Pública de Navarra - IdiSNA, Pamplona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Spain.
Complejo Hospitalario de Navarra - IdiSNA, Pamplona, Spain.
Vaccine. 2020 Feb 18;38(8):1925-1932. doi: 10.1016/j.vaccine.2020.01.028. Epub 2020 Jan 22.
The population targeted for influenza vaccination can be repeatedly vaccinated over successive seasons, and vaccines received in previous seasons may retain preventive effect. This study aims to estimate the effectiveness of inactivated influenza vaccines received in the current and prior seasons in the 2018-2019 season.
Influenza-like illness patients attended by sentinel general practitioners or admitted to hospitals in Navarre, Spain, were tested for influenza. Vaccination status in the current and three prior seasons was obtained from the vaccination registry. The test-negative design was used to estimate the vaccine effectiveness.
A total of 381 influenza A(H1N1)pdm09 cases, 341 A(H3N2) cases and 1222 controls were analysed. As compared to individuals unvaccinated in the current and three prior seasons, the influenza vaccine effectiveness against A(H1N1)pdm09 was 57% (95% confidence interval [CI]: 40%, 70%) for current season vaccination regardless of prior doses and 48% (95%CI: 14%, 68%) for vaccination in prior seasons but not in the current season. These estimates were 12% (95%CI: -23%, 37%) and 27% (95%CI: -22%, 56%), respectively, against influenza A(H3N2). Individuals vaccinated with the two A(H1N1)pdm09 strains in influenza vaccines since 2009, A/Michigan/45/2015 and A/California/07/2009, had higher protection (68%; 95%CI: 53%, 77%) than those vaccinated with A/Michigan/45/2015 only (29%, p = 0.020) or with A/California/07/2009 only (34%, p = 0.005).
These results suggest moderate effectiveness of influenza vaccination against A(H1N1)pdm09 and low effectiveness against A(H3N2) influenza in the 2018-2019 season. Vaccination in prior seasons maintained a notable protective effect. Strains included in previous vaccines were as effective as the current vaccine strain, and both added their effects against influenza A(H1N1)pdm09.
针对流感接种的人群可以在连续的季节中多次接种疫苗,并且前几个季节接种的疫苗可能仍具有预防作用。本研究旨在评估 2018-2019 年季节中当前和前几季接种的灭活流感疫苗的效果。
西班牙纳瓦拉的哨点全科医生就诊或住院的流感样疾病患者进行了流感检测。从疫苗接种登记处获得了当前和前三个季节的接种情况。使用阴性对照设计来估计疫苗的有效性。
共分析了 381 例甲型 H1N1pdm09 病例、341 例甲型 H3N2 病例和 1222 例对照。与当前和前三个季节未接种疫苗的个体相比,当前季节接种流感疫苗对甲型 H1N1pdm09 的疫苗有效性为 57%(95%置信区间[CI]:40%,70%),而前几个季节接种疫苗但当前季节未接种疫苗的有效性为 48%(95%CI:14%,68%)。这些估计值分别为 12%(95%CI:-23%,37%)和 27%(95%CI:-22%,56%),分别针对甲型 H3N2。自 2009 年以来,接种了两种甲型 H1N1pdm09 株(A/Michigan/45/2015 和 A/California/07/2009)的流感疫苗的个体的保护作用更高(68%;95%CI:53%,77%),而仅接种 A/Michigan/45/2015(29%,p=0.020)或仅接种 A/California/07/2009(34%,p=0.005)的个体的保护作用较低。
这些结果表明,在 2018-2019 年季节中,流感疫苗对甲型 H1N1pdm09 的有效性中等,对甲型 H3N2 流感的有效性低。前几个季节的疫苗接种保持了显著的保护作用。包含在前几批疫苗中的毒株与当前疫苗株一样有效,并且两者都增加了对甲型 H1N1pdm09 的效果。